Table of Contents
PPT Slide
MOHLTC Vision
ODB Statistics, 2000/01-2001/02
ODB Statistics, 2000/01-2001/02
ODB Statistics, 2000/01-2001/02
Introduction
Growth Factors
Report Card Framework
Definitions
I. Financial Indicators
ODB Beneficiaries & Claims 1993/94 – 2001/02
Government Cost & Patient Cost 1993/94 – 2001/02
Total Cost by Type of Spending 1995/96-2001/02
Age Distribution of Beneficiaries 1993/94-2001/02
Share of Seniors, 1993/94 vs. 2001/02
Drug Cost & Beneficiary Distribution by Age, 2001/02
Change in Drug Cost & Beneficiaries by Age, 2000/01-2001/02
Drug Cost & Beneficiary Distribution by Program, 2001/02
Change in Drug Cost & Beneficiaries by Program, 2000/01-2001/02
Eligible Recipients and Utilizing Percentage by Program, 2002
Drug Cost Concentration 5% Intervals, 2001/02
Trend in Drug Cost Concentration 5% Intervals, 2001/02
Summary on Financial
Summary on Financial
II. Clinical/Evidence Based Indicators
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
PPT Slide
Prescribing Guidelines
Drug Utilization Reviews
Drug Utilization Advisory Committee
Clinical Criteria and Reimbursement
Summary on Clinical Indicators
III. Customer Satisfaction Indicators
Monthly Section 8 Requests January 1997 - January 2002
PPT Slide
Section 8 Requests and Response Time
Individual Clinical Review (Section 8), 2001
PPT Slide
DPB Review Timeline Products Listed in 2000 & 2001
PPT Slide
Limited Use Tripartite Committee
Customer Service Standards
Summary Customer Satisfaction
IV. Operational Policy Indicators/Initiatives
Written Agreements by Therapeutic Class, 2001/02
Written Agreements Experience to Date
2001/02 Achievements
2001/02 Achievements
V. Impact of Limited Use Policy
Main Classes of LU Products 2001 (Calendar Year)
Distribution of LU Costs Senior Programs, 2001 (Calendar Year)
Cost per Claim of Selected LU Products, Senior Programs, 2001
Market Share (Claims) of LU Products, by Province, Senior Programs, 2001 (Calendar Year)
Cost Avoidance with LU Selected Classes, Senior Programs, 2001 (Calendar Year)
Total Cost with and without Limited Use, 2001 (Calendar Year)
VI. Case Study Alzheimer Disease
Canadian Population Projection, 2001-2021
Expected Number of AD Cases, 2001-2021
Expected Evolution of Alzheimer Cohort
Annual Cost of Caring for Alzheimer Patients, (1996 dollars)
Cost of Alzheimer Drugs ODB, 1999/00-2001/02
Expected Age-Related Increase, Alzheimer Drug Cost, 2001-2026
% Claimants vs. Estimated Alzheimer Cases, Ontario, 2001
Reimbursement Criteria for Alzheimer Products
Alzheimer Persistency All Alzheimer Drugs, ODB
Alzheimer Compliance All Alzheimer Drugs, ODB
Key Findings on Alzheimer
Key Findings on Alzheimer
|
Author: Veronique Ouellette Fohr
Best experienced with
Click here to start.
Download presentation source
|